Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Circumsporozoite protein (CSP) is the major surface protein of the sporozoite stage of malaria parasites belonging to the genus *Plasmodium*. It is a secreted, glycosylphosphatidylinositol (GPI)-anchored protein that forms a dense coat on the parasite's surface and plays essential roles in parasite development, motility, and host cell invasion. CSP is the antigenic target of leading malaria vaccines such as RTS,S. It facilitates migration from oocysts in mosquito midguts to salivary glands and subsequently enables binding and invasion of hepatocytes (liver cells) in mammals. Proteolytic cleavage regulates exposure/switching between adhesive/nonadhesive conformations required for successful transition between migratory states within hosts versus invasive states during liver entry.
Antibodies against CSP block sporozoite invasion of hepatocytes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Circumsporozoite Protein (None).